C.M. Bidwell & Associates’s Teladoc Health TDOC Stock Holding History

C.M. Bidwell & Associates’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$127	Hold	15	–	–	﹤0.01%	490
2026 Q1	$82	Hold	15	–	–	﹤0.01%	478
2025 Q4	$105	Hold	15	–	–	﹤0.01%	481
2025 Q3	$116	Hold	15	–	–	﹤0.01%	485
2025 Q2	$131	Hold	15	–	–	﹤0.01%	442
2025 Q1	$119	Hold	15	–	–	﹤0.01%	435
2024 Q4	$136	Sell	15 -71	-83%	-$686	﹤0.01%	482
2024 Q3	$789	Hold	86	–	–	﹤0.01%	450
2024 Q2	$841	Hold	86	–	–	﹤0.01%	422
2024 Q1	$1.3K	Hold	86	–	–	﹤0.01%	417
2023 Q4	$1.85K	Hold	86	–	–	﹤0.01%	429
2023 Q3	$1.6K	Sell	86 -6,809	-99%	-$159K	﹤0.01%	491
2023 Q2	$175K	Buy	6,895 +6,809	+7,917%	+$171K	0.13%	139
2023 Q1	$2.23K	Hold	86	–	–	﹤0.01%	452
2022 Q4	$2.03K	Buy	+86	New	+$2.32K	﹤0.01%	452
2022 Q2	–	Sell	-79	Closed	-$6K	–	557
2022 Q1	$6K	Buy	79 +15	+23%	+$1.08K	﹤0.01%	400
2021 Q4	$6K	Hold	64	–	–	﹤0.01%	422
2021 Q3	$8K	Hold	64	–	–	0.01%	406
2021 Q2	$11K	Buy	+64	New	+$10.4K	0.01%	393
2020 Q3	–	Sell	-845	Closed	-$161K	–	511
2020 Q2	$161K	Sell	845 -948	-53%	-$166K	0.15%	152
2020 Q1	$278K	Buy	+1,793	New	+$209K	0.29%	88

Other funds holding TDOC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

C.M. Bidwell & Associates's TDOC Position: Q2 2026 in Review

C.M. Bidwell & Associates held its Teladoc Health (TDOC) position steady in Q2 2026 at 15 shares worth $127. The position accounts for ﹤0.01% of the portfolio, ranked #490.

C.M. Bidwell & Associates first reported a position in TDOC in Q1 2020 and has held it in 21 quarters since. The position peaked at $278K in Q1 2020. 347 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

C.M. Bidwell & Associates held 15 shares of Teladoc Health worth $127 as of Q2 2026.
C.M. Bidwell & Associates left its Teladoc Health share count unchanged in Q2 2026.
Teladoc Health made up ﹤0.01% of C.M. Bidwell & Associates's portfolio in Q2 2026, its #490 holding.
C.M. Bidwell & Associates first reported a position in Teladoc Health in Q1 2020 and has held it in 21 quarters since.
C.M. Bidwell & Associates's Teladoc Health position peaked at $278K in Q1 2020.
347 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on C.M. Bidwell & Associates's 13F filing for Q2 2026, filed 11 Aug 2026.